Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Sort descending Program Official
Notice of Intent to Publish a Funding Opportunity Announcement for Human Virome Project: Developing novel and innovative tools to interrogate and annotate the human virome NOT-RM-23-014 (U01 Clinical Trial Not Allowed) U01 Clinical Trial Not Allowed 07/31/2024 Sharon Ross, Ph.D., M.P.H.
Notice of Intent to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Characterize the Human Virome in Longitudinal, Diverse Cohorts Across the Lifespan NOT-RM-23-017 (U54 Clinical Trial Not Allowed) U54 Clinical Trial Not Allowed 07/31/2024 Sharon Ross, Ph.D., M.P.H.
Notice of Intent to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Characterization of functional interactions between viruses and human and microbial hosts NOT-RM-23-015 (U01 Clinical Trial Not Allowed) U01 Clinical Trial Not Allowed 07/31/2024 Sharon Ross, Ph.D., M.P.H.
Notice of Intent to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Consortium Organization and Data Collaboration Center (CODCC) for the Human Virome Project (HVP) NOT-RM-23-016 (U24 Clinical Trial Not Allowed) U24 Clinical Trial Not Allowed 07/31/2024 Sharon Ross, Ph.D., M.P.H.
Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk NOT-CA-23-089 09/08/2024 Edward Sauter, M.D., Ph.D.
Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention NOT-CA-21-121 09/08/2024 Sharon Ross, Ph.D., M.P.H.
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer PAR-22-061 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 01/08/2025 Young Kim, Ph.D.
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) NOT-OD-22-202 Clinical Trial Not Allowed 04/16/2025 Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
NCI Clinical and Translational Exploratory/Developmental Studies PAR-22-216 (R21 Clinical Trial Optional) R21 Clinical Trial Optional 07/02/2025 Marjorie Perloff, M.D.
Notice of Special Interest (NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases NOT-DA-22-048 01/08/2026 Sharon Ross, Ph.D., M.P.H.